Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Frontiers in Cardiovascular Medicine|July 5, 2022
RBM20, a Therapeutic Target to Alleviate Myocardial Stiffness via Titin Isoforms Switching in HFpEFNa Li, Weijian Hang, Hongyang Shu, et al.Journal of Cellular and Molecular Medicine|July 21, 2022
Pirfenidone alleviates cardiac fibrosis induced by pressure overload via inhibiting TGF-β1/Smad3 signalling pathwayNa Li, Weijian Hang, Hongyang Shu, et al.Journal of Molecular and Cellular Cardiology|June 12, 2020
Cardiac injuries in coronavirus disease 2019 (COVID-19)Chen Chen, Huihui Li, Weijian Hang, et al.Signal Transduction and Targeted Therapy|December 11, 2020
Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomesWeijian Hang, Chen Chen, John M Seubert, et al.Frontiers of Medicine|March 22, 2021
Endothelial dysfunction in COVID-19 calls for immediate attention: the emerging roles of the endothelium in inflammation caused by SARS-CoV-2Weijian Hang, Chen Chen, Xin A Zhang, et al.Frontiers in Pharmacology|February 18, 2021
Trimetazidine in Heart FailureHongyang Shu, Yizhong Peng, Weijian Hang, et al.Biochemical Society Transactions|January 13, 2021
Emerging role of VCP/p97 in cardiovascular diseases: novel insights and therapeutic opportunitiesHongyang Shu, Yizhong Peng, Weijian Hang, et al.Journal of Translational Internal Medicine|August 27, 2025
The roles of subcellular Argonaute 2 in cardiovascular diseasesYifan Cai, Weijian Hang, Rong Xie, et al.The American Journal of Chinese Medicine|September 19, 2022
Salvianolic Acid Ameliorates Pressure Overload-Induced Cardiac Endothelial Dysfunction via Activating HIF1[Formula: see text]/HSF1/CD31 PathwayNa Li, Weijian Hang, Hongyang Shu, et al.Cardiovascular Research|November 19, 2020
The role of CD36 in cardiovascular diseaseHongyang Shu, Yizhong Peng, Weijian Hang, et al.Pageof 3